Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn practical checks and habits to avoid common budgeting traps, helping you maintain discipline and achieve long-term financial balance.
14,965 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Meta and Amazon are at the forefront of a trillion-dollar Big Tech capex surge, led by AI infrastructure and data-cen...
SBI Holdings, Ripple’s biggest shareholder outside the United States, is quietly developing institutional XRP lending...
In a high-profile auction tied to Berkshire's annual meeting, a signed commemorative book changed hands for $50,000, ...
Wildfire smoke blankets major U.S. cities, pushing air quality warnings higher and nudging investment flows toward cl...
A growing number of high-earning pilots are reconsidering when to convert 401(k) funds to a Roth. Experts warn that r...
A new breed of daily-reset covered-call ETFs aims to preserve more upside while delivering monthly income. Here’s how...
Alphabet’s Q1 2026 results show stronger-than-expected search growth and record cloud momentum, challenging the AI be...
Buffett’s moat mindset helps explain Netflix's AI edge. This article breaks down why the advantage may be temporary a...
Amazon shocks privacy watchers by ending its partnership with Flock Safety after a controversial Super Bowl ad. The m...
US spot Bitcoin ETFs have shed about $8 billion since October, stoking a provocative debate on whether bitcoin etfs w...
Anthropic's $200 million DoD contract is under scrutiny after reports about Claude's deployment in a January raid. Th...